Historical shareholding details of Strategic Advisers U.S. Total Stock holdings in Alnylam Pharmaceuticals Inc (ALNY)

Monthly changes of Strategic Advisers U.S. Total Stock shareholding in Alnylam Pharmaceuticals Inc over the previous months

Month	Name	Total no. shares held	Percent Holding
Month	Name	Total no. shares held	Percent Holding
Jan 31, 2025	Strategic Advisers U.S. Total Stock	42,785	0.03%

Dec 31, 2024	Strategic Advisers U.S. Total Stock	43,085	0.03%

Nov 30, 2024	Strategic Advisers U.S. Total Stock	43,685	0.03%

Oct 31, 2024	Strategic Advisers U.S. Total Stock	48,473	0.04%

Sep 30, 2024	Strategic Advisers U.S. Total Stock	49,851	0.04%

Jul 31, 2024	Strategic Advisers U.S. Total Stock	56,288	0.04%

Jun 30, 2024	Strategic Advisers Large Cap	46,888	0.04%

May 31, 2024	Strategic Advisers Large Cap	35,088	0.03%

Apr 30, 2024	Strategic Advisers Large Cap	32,588	0.03%

Mar 31, 2024	Strategic Advisers Large Cap	29,488	0.02%

Feb 29, 2024	Strategic Advisers Large Cap	12,528	0.01%

Jan 31, 2024	Strategic Advisers Large Cap	11,728	0.01%

Dec 31, 2023	Strategic Advisers Large Cap	11,828	0.01%

Oct 31, 2023	Strategic Advisers® Large Cap	13,628	0.01%

Sep 30, 2023	Strategic Advisers® Large Cap	16,128	0.01%

Jul 31, 2023	Strategic Advisers® Large Cap	19,577	0.02%

Jun 30, 2023	Strategic Advisers® Large Cap	19,721	0.02%

Apr 30, 2023	Strategic Advisers® Large Cap	19,921	0.02%